On ECHEMI
Home > Drugs > Insulin resistance and metabolic syndrome
Insulin resistance and metabolic syndrome
Insulin resistance is one of the hot issues that everyone is concerned about. As early as the 1960s, people observed that impaired glucose tolerance (IGT), diabetes, obesity, lipid metabolism disorders and hypertension often appeared simultaneously in the same individual. At that time, some people called it prosperity syndrome, but for a long time people did not understand why the various components of the syndrome appeared successively or simultaneously in the same individual or the same family, so it was also called X syndrome. It was not until Reaven first proposed the insulin resistance syndrome in 1988 that people linked the above-mentioned manifestations with insulin resistance and believed that their common pathological basis for the onset of the disease was insulin resistance. The definition of insulin resistance: the body's reduced responsiveness or sensitivity to the physiological effects of insulin. Insulin resistance in a narrow sense refers to the reduced responsiveness of tissue cells to insulin-mediated glucose utilization. The main sites of insulin resistance are the liver, muscle and adipose tissue.
  • Site of disease:

    Pancreas whole body
  • Infectious :

    Not contagious
  • Frequent population:

    All groups
  • Related symptoms:

    Diabetes Visceral obesity Proteinuria High blood pressure Central obesity
  • Concurrent disease:

Related Drugs
Phenformin Hydrochloride Tablets
Indication: It is used for patients with type 2 diabetes who are not satisfied with diet control alone, especially those who are obese and have hyperinsulinemia. This drug not only has the effect of lowering blood sugar, but also has the effect of reducing weight and hyperinsulinemia. It can be effective for patients with poor response to certain sulfonylureas. For example, it is more effective when used in combination with sulfonylurea hypoglycemic drugs, intestinal glycosidase inhibitors or thiazolidinedione hypoglycemic drugs than when used alone. It can also be used for patients treated with insulin to reduce the amount of insulin used.
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.